The following information is based on a press release from Q-Med AB (Q-Med) dated March 11, 2011 and may be subject to change.
On December 13, 2010, Galderma Holding AB (Galderma) announced a public takeover offer to the shareholders of Q-Med. On February 10, 2011 the offer was revised whereby every one (1) Q-med share held entitles their holder to a cash payment of SEK 79.00.
The last trading date is March 25, 2011. NASDAQ OMX Derivatives Markets will (1) set a new expiration day for options and forward contracts in Q-Med to March 22, 2011, alternatively when trading is considered to be insufficient to support related derivatives trading and (2) settle the contracts at Fair Value.
For further information, please see the attached file or contact Mandus Petersson +46 8 405 6682 or Carina Frostig +46 8 405 6653.
